The Hemp Industries Association and a South Carolina CBD maker are trying to get U.S. Drug Enforcement Administration to clarify whether it considers temporary byproducts of hemp production a Schedule 1 substance. In a filing Monday in U.S. District Court in Washington DC, HIA and RE Botanicals ask a judge to order the DEA to […]
Hemp industry pushing DEA to address byproducts is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
From Hemp industry pushing DEA to address byproducts on CBD Products & CBD Business News – Hemp Industry Daily.
This was autoposted by IFTTT. To find out more, read my post about news articles.
Looking CBD for pain relief cream or lotion? Look no further! Infuzion offers a wide range of CBD products which helps in chronic pain, joint pain, inflammation and neuropathic pain. Shop now!
ReplyDelete